Director/PDMR Shareholding

RNS Number : 7796Q
Inspiration Healthcare Group PLC
29 October 2021
 

 29 October 2021

 

 

 

 

 

INSPIRATION HEALTHCARE GROUP PLC

(the "Company")

 

Director / PDMR Dealing

The Company has been notified that on 29 October 2021, Neil Campbell, Chief Executive of the Company and a person discharging managerial responsibility ("PDMR") in the Company, sold 100,000 ordinary shares of 10 pence   each in the Company ("Ordinary Shares") at a price of 134.5 pence per share . Mr Campbell has made the share sale to cover the cost of a one-off exceptional expense. Mr Campbell has indicated to the Company that he has no intention to sell any further Ordinary Shares at this time.

 

Following the sale, Mr Campbell holds an interest in 4,416,646 Ordinary Shares, representing approximately   6.48 per cent. of the Company's issued ordinary share capital.

 

This announcement, including the notification below, is made in accordance with the requirements of the UK Market Abuse Regulation.

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a.

Name

Neil Campbell

2

Reason for notification

 

a.

Position/Status

Chief Executive

b.

Initial notification/

Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

INSPIRATION HEALTHCARE GROUP PLC

 

b.

LEI

213800GKFT3ENAPMDL15

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the financial instrument, type of instrument

Identification Code

Ordinary Shares of 10 p each

 

ISIN: GB00BXDZL105

b.

Nature of the transaction

Sale of Ordinary Shares

c.

Price(s) and volume(s)

 

 

 

 

 

 

Price(s)

Volume(s)

 

134.5 p

100,000

 

 

 

d.

Aggregated information

- Aggregated Volume

- Price

 

N/A

e.

Date of the transaction

29 October 2021

f.

Place of the transaction

XLON (AIM)

                 

 

Enquiries:

Inspiration Healthcare Group plc
Neil Campbell, Chief Executive Officer
Jonathan Ballard, Chief Financial Officer

 

Tel: 01455 840 555

 

Cenkos Securities plc - Nominated Adviser & Broker
Mark Connelly / Stephen Keys

Tel: 0207 397 8900

 

Cadogan PR
Alex Walters
alex.walters@cadoganpr.com

Tel: 07771 713 608

 

 

 

About Inspiration Healthcare

Inspiration Healthcare (AIM: IHC) is a global provider of medical technology for use in critical care & operating theatres. The Company provides high quality innovative products to patients around the world which help to improve patient outcomes and it actively invests in innovative product opportunities and disruptive technologies. 

Through investment in research and development the Company has 6 key own brand products that can be used within the first 6 hours of life to help premature and sick babies; helping with assessment, resuscitation, stabilisation as well as preventing brain damage. Additionally, the Company has its own range of products for maintaining normothermia pre- during and post-surgery.

With product availability extending to over 50 countries through a distribution network, Inspiration Healthcare's success has been built on continuous innovation, excellent customer service and an inherent commitment to improving patient outcomes, working in close collaboration with key opinion leaders across the globe.

In the UK and Ireland, the Company has a direct sales team selling Inspiration Branded and complementary products from third parties, with an additional range of home healthcare products.  This is supported by Technical Support for planned preventative maintenance and emergency assistance.

Further information on Inspiration Healthcare can be seen at  www.inspiration-healthcare.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFISIRLAFIL
UK 100

Latest directors dealings